Comments on: Novartis invests $24M in Proteus Biomedical

By: Lloyds Pharmacies to sell Proteus smart pills, sensors | mobihealthnews

Lloyds Pharmacies to sell Proteus smart pills, sensors | mobihealthnews — Fri, 13 Jan 2012 16:34:54 +0000

[...] it launched its system in — not the US or UK. In early 2010 Novartis announced that it had invested $24 million in Proteus and that it had exclusive rights to use the technology with specific types of therapies, [...]

By: Proteus receives patent for ingestible sensor | mobihealthnews

Proteus receives patent for ingestible sensor | mobihealthnews — Fri, 15 Jul 2011 00:44:54 +0000

[...] new information about Proteus’ partners: While the Novartis relationship had been previously announced, the company said it was also working with Medtronic, ON Semiconductor, Kaiser Permanente and Avery [...]

By: FDA health app regulation won’t cost $30M | mobihealthnews

FDA health app regulation won’t cost $30M | mobihealthnews — Thu, 21 Apr 2011 12:15:39 +0000

[...] stating that Novartis had an exclusive deal with Proteus for all of its drug delivery technology, because we had reported the exclusivity was only for certain use cases, including organ transplant drugs. A rep from one of the companies confirmed the report’s [...]

By: Is passivity the future for home health monitoring? | mobihealthnews

Is passivity the future for home health monitoring? | mobihealthnews — Tue, 01 Mar 2011 17:20:00 +0000

[...] about a penny, pharmaceutical companies can add a digestible chip to a pill to indicate whether the patient took the drug, monitor stomach pH and other vitals, and transmit [...]

By: Novartis seeks regulatory approval for Proteus | mobihealthnews

Novartis seeks regulatory approval for Proteus | mobihealthnews — Wed, 10 Nov 2010 17:01:34 +0000

[...] January Novartis announced that would invest $24 million in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus [...]

By: New ways to make you take your meds - SmartPlanet

New ways to make you take your meds - SmartPlanet — Mon, 07 Jun 2010 19:21:34 +0000

[...] so can the patient’s family. No more relying on your own memory. Novartis has already paid $24 million for the marketing [...]

By: FDA grants Proteus Biomedical 510(k) clearance | mobihealthnews

FDA grants Proteus Biomedical 510(k) clearance | mobihealthnews — Wed, 21 Apr 2010 17:45:15 +0000

[...] Proteus also disclosed that it had raised $25 million in series E financing. When Proteus announced the deal with Novartis in January, it noted that Novartis had contributed $24 million as a strategic investment. It seems [...]

By: Analysis: Rationale and challenges to Novartis-Proteus | mobihealthnews

Analysis: Rationale and challenges to Novartis-Proteus | mobihealthnews — Tue, 19 Jan 2010 13:23:23 +0000

[...] to a report in the Economist, pharmaceuticals company Novartis’ $24 million investment in intelligent medicine startup Proteus Biomedical may be just as important in the long run as [...]